Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ENZ

Enzo Biochem (ENZ) Stock Price, News & Analysis

Enzo Biochem logo

About Enzo Biochem Stock (NYSE:ENZ)

Key Stats

Today's Range
$0.31
$0.40
50-Day Range
$0.33
$0.33
52-Week Range
$0.25
$1.19
Volume
4.12 million shs
Average Volume
173,401 shs
Market Capitalization
$17.03 million
P/E Ratio
N/A
Dividend Yield
123.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ENZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ENZ Stock News Headlines

Battery Ventures Completes Take-Private of Enzo Biochem
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.tc pixel
ENZB - Enzo Biochem Inc Dividends - Morningstar
See More Headlines

ENZ Stock Analysis - Frequently Asked Questions

Enzo Biochem, Inc. (NYSE:ENZ) issued its earnings results on Monday, March, 17th. The medical research company reported ($0.02) earnings per share (EPS) for the quarter. The medical research company earned $7.33 million during the quarter. Enzo Biochem had a negative trailing twelve-month return on equity of 7.96% and a negative net margin of 75.34%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enzo Biochem investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), AST SpaceMobile (ASTS), Virgin Galactic (SPCE) and OneLife Technologies (OLMM).

Company Calendar

Last Earnings
3/17/2025
Today
10/19/2025
Fiscal Year End
7/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NYSE:ENZ
CIK
316253
Employees
520
Year Founded
1976

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.08 million
Net Margins
-75.34%
Pretax Margin
-23.79%
Return on Equity
-7.96%
Return on Assets
-5.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.55
Quick Ratio
2.28

Sales & Book Value

Annual Sales
$29.09 million
Price / Sales
0.59
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.09 per share
Price / Book
0.30

Miscellaneous

Outstanding Shares
52,403,000
Free Float
46,288,000
Market Cap
$17.03 million
Optionable
Optionable
Beta
1.19

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NYSE:ENZ) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners